StockNews.com started coverage on shares of Invitae (NYSE:NVTA – Free Report) in a research note published on Wednesday. The firm issued a hold rating on the medical research company’s stock.
Invitae Stock Up 900.0 %
NVTA stock opened at $0.01 on Wednesday. Invitae has a 52-week low of $0.02 and a 52-week high of $0.02. The firm has a market cap of $2.40 million, a PE ratio of 0.00 and a beta of 1.59.
Institutional Investors Weigh In On Invitae
A number of institutional investors have recently modified their holdings of the company. Vestmark Advisory Solutions Inc. acquired a new stake in Invitae in the fourth quarter worth $526,000. Prosperity Wealth Management Inc. acquired a new stake in shares of Invitae in the 4th quarter valued at about $144,000. Bourne Lent Asset Management Inc. grew its stake in shares of Invitae by 53.3% in the 4th quarter. Bourne Lent Asset Management Inc. now owns 574,600 shares of the medical research company’s stock valued at $360,000 after buying an additional 199,900 shares during the period. SG Americas Securities LLC increased its position in Invitae by 90.7% in the 4th quarter. SG Americas Securities LLC now owns 91,937 shares of the medical research company’s stock valued at $58,000 after buying an additional 43,717 shares in the last quarter. Finally, Green Alpha Advisors LLC raised its stake in Invitae by 138.4% during the 4th quarter. Green Alpha Advisors LLC now owns 452,585 shares of the medical research company’s stock worth $284,000 after buying an additional 262,760 shares during the period. 61.28% of the stock is owned by institutional investors.
Invitae Company Profile
Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services.
Featured Articles
- Five stocks we like better than Invitae
- Earnings Per Share Calculator: How to Calculate EPS
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- Technology Stocks Explained: Here’s What to Know About Tech
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Short Selling: How to Short a Stock
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Invitae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae and related companies with MarketBeat.com's FREE daily email newsletter.
